BTIG Maintains Buy on DexCom, Raises Price Target to $96

Benzinga Newsdesk www.benzinga.com Positive 63.0%

Neg 0% Neu 0% Pos 63%

BTIG analyst Ryan Zimmerman maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $90 to $96.

Comments

No comments yet. Be the first!